Cargando…
Anti-CD3 Fab Fragments Enhance Tumor Killing by Human γδ T Cells Independent of Nck Recruitment to the γδ T Cell Antigen Receptor
T lymphocytes expressing the γδ T cell receptor (γδ TCR) can recognize antigens expressed by tumor cells and subsequently kill these cells. γδ T cells are indeed used in cancer immunotherapy clinical trials. The anti-CD3ε antibody UCHT1 enhanced the in vitro tumor killing activity of human γδ T cell...
Autores principales: | Juraske, Claudia, Wipa, Piyamaporn, Morath, Anna, Hidalgo, Jose Villacorta, Hartl, Frederike A., Raute, Katrin, Oberg, Hans-Heinrich, Wesch, Daniela, Fisch, Paul, Minguet, Susana, Pongcharoen, Sutatip, Schamel, Wolfgang W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6046647/ https://www.ncbi.nlm.nih.gov/pubmed/30038626 http://dx.doi.org/10.3389/fimmu.2018.01579 |
Ejemplares similares
-
Cooperative Interaction of Nck and Lck Orchestrates Optimal TCR Signaling
por: Hartl, Frederike A., et al.
Publicado: (2021) -
Lack of Nck1 protein and Nck-CD3 interaction caused the increment of lipid content in Jurkat T cells
por: Nuiyen, Aussanee, et al.
Publicado: (2022) -
Non-overlapping functions of Nck1 and Nck2 adaptor proteins in T cell activation
por: Ngoenkam, Jatuporn, et al.
Publicado: (2014) -
Wiskott-Aldrich Syndrome Protein: Roles in Signal Transduction in T Cells
por: Ngoenkam, Jatuporn, et al.
Publicado: (2021) -
Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy
por: Oberg, Hans-Heinrich, et al.
Publicado: (2014)